Published online Oct 27, 2024. doi: 10.4240/wjgs.v16.i10.3091
Revised: June 28, 2024
Accepted: July 9, 2024
Published online: October 27, 2024
Processing time: 142 Days and 5.8 Hours
This editorial offers commentary on the article which aimed to forecast the likelihood of short-term major postoperative complications (Clavien-Dindo grade ≥ III), including anastomotic fistula, intra-abdominal sepsis, bleeding, and intestinal obstruction within 30 days, as well as prolonged hospital stays follow
Core Tip: Preoperative optimization for patients with Crohn's disease presents numerous challenges. Traditional research methods are insufficient to address the expanding array of questions in this field. Hence, there is a growing need to explore and develop new tools grounded in advanced technologies, such as computer simulation models and artificial intelligence. Employing machine learning approaches can significantly enhance patient risk stratification and the formulation of preoperative optimization strategies, ultimately aiming to improve post-surgical outcomes.
- Citation: Nardone OM, Castiglione F, Maurea S. Advancing perioperative optimization in Crohn's disease surgery with machine learning predictions. World J Gastrointest Surg 2024; 16(10): 3091-3093
- URL: https://www.wjgnet.com/1948-9366/full/v16/i10/3091.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v16.i10.3091
A substantial portion of Crohn’s disease (CD) patients still undergo surgery over their lifetime despite advancements in medical therapies. Managing CD patients undergoing surgery is complex and necessitates integrated care with multidisciplinary approaches to improve clinical outcomes[1,2].
Wang et al[3] were the first to utilize a machine learning (ML) model trained on a cohort, integrating a nomogram predictive model from logistic regression analysis and a random forest (RF) model. This model aimed to predict the probability of short-term major postoperative complications (Clavien-Dindo ≥ III) encompassing anastomotic fistula, intra-abdominal sepsis complications, bleeding, and intestinal obstruction within 30 days and prolonged hospital stays following ileocecal resection in patients with CD.
A total of 259 patients were randomly assigned to either a training or validation cohort. Logistic regression and RF models were developed using the training cohort, while the performance of these models was evaluated using the validation cohort. Overall, 5.0% of patients experienced major complications within 30 days after surgery. Key factors influencing these complications in both models included a CD activity index ≥ 220, longer operation times, and lower preoperative albumin levels. While independent risk factors significantly associated with a longer postoperative hospital stay included lower preoperative hemoglobin levels, emergency surgery, laparotomy approach, and longer operation duration.
In the landscape of cutting-edge medicine and advanced methodologies, this paper presents an innovative approach to post-operative complications. ML algorithms are pivotal in constructing predictive models that mitigate risk factors, assisting clinical decision-makers and improving patient outcomes. The study's findings can guide patient and surgeon preparation for surgery and postoperative recovery. Indeed, emphasizing preoperative optimization is crucial for identifying high-risk patients and providing personalized perioperative management to enhance outcomes.
Nevertheless, the current study did not provide any substantial advancements or novel insights into the field. Yet, there are several points that deserve attention. The authors mainly focused on the assessment of nutritional status. However, the assessment of muscle mass, strength and function, key components of sarcopenia, is now included in the optimal perioperative care roadmap for inflammatory bowel disease (IBD) and should be considered in ML prediction models[4].
Notably, sarcopenia and malnutrition have been associated with increased hospitalizations, disease flares, the need for surgery, and postoperative complications in patients with IBD[5,6].
Furthermore, hypoalbuminemia is commonly used as an indicator for malnutrition, although it does not accurately reflect total body protein or muscle mass. Hence, it should not be solely relied upon as a marker of nutritional status. Preoperative hypoalbuminemia may also suggest systemic inflammation, given that both albumin and prealbumin levels decrease as part of the acute-phase response during inflammation[7]. However, supplementation of albumin remains fundamental.
Another aspect worthy of consideration and further exploration is the use of medical treatment prior to surgery. Indeed, most IBD patients undergoing surgery receive concomitant treatment with medications such as steroids, immunomodulators and biologics. Biologic agents and immune modulators may be continued, but steroids should be withdrawn or tapered to the minimum required dose[4]. Corticosteroids remain the most significant and modifiable risk factor associated with postoperative infection and complications[4,8,9]. Patients who received corticosteroids before surgery showed a 3.7-fold increase in the likelihood of experiencing any postoperative complications and a 5.5-fold increase in the likelihood of developing major infectious complications[10,11]. Similarly, the preoperative use of oral antibiotics should be considered. Recently, the rate of septic intra-abdominal complications was significantly reduced by pre-operative mechanical bowel preparation combined with pre-operative oral antibiotics (paromomycin and metronidazole) on the day before surgery[12]. Nonetheless, prolonged use of antibiotics raises the risk of Clostridium difficile infection or the development of antibiotic resistance[13]. However, in the near future, the integration of medications into ML prediction models should be considered in predicting CD surgery complications.
In conclusion, preoperative optimization for patients with CD still presents numerous challenges. Traditional research methods fall short in addressing the expanding array of questions in this field. Integrating ML artificial intelligence models will significantly enhance patient risk stratification and the development of personalized preoperative optimization strategies.
1. | Buisson A, Chevaux JB, Allen PB, Bommelaer G, Peyrin-Biroulet L. Review article: the natural history of postoperative Crohn's disease recurrence. Aliment Pharmacol Ther. 2012;35:625-633. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 232] [Cited by in F6Publishing: 254] [Article Influence: 21.2] [Reference Citation Analysis (0)] |
2. | Frolkis AD, Dykeman J, Negrón ME, Debruyn J, Jette N, Fiest KM, Frolkis T, Barkema HW, Rioux KP, Panaccione R, Ghosh S, Wiebe S, Kaplan GG. Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies. Gastroenterology. 2013;145:996-1006. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 536] [Cited by in F6Publishing: 625] [Article Influence: 56.8] [Reference Citation Analysis (0)] |
3. | Wang FT, Lin Y, Yuan XQ, Gao RY, Wu XC, Xu WW, Wu TQ, Xia K, Jiao YR, Yin L, Chen CQ. Predicting short-term major postoperative complications in intestinal resection for Crohn's disease: A machine learning-based study. World J Gastrointest Surg. 2024;16:717-730. [PubMed] [DOI] [Cited in This Article: ] [Reference Citation Analysis (0)] |
4. | Sebastian S, Segal JP, Hedin C, Pellino G, Kotze PG, Adamina M, Campmans-Kuijpers M, Davies J, de Vries AC, Casbas AG, El-Hussuna A, Juillerat P, Meade S, Millán M, Spinelli A. ECCO Topical Review: Roadmap to Optimal Peri-Operative Care in IBD. J Crohns Colitis. 2023;17:153-169. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 1] [Cited by in F6Publishing: 15] [Article Influence: 15.0] [Reference Citation Analysis (0)] |
5. | Nardone OM, Armuzzi A. Sarcopenia: A new route on the map for risk stratification in inflammatory bowel disease. Dig Liver Dis. 2023;55:829-830. [PubMed] [DOI] [Cited in This Article: ] [Cited by in F6Publishing: 4] [Reference Citation Analysis (0)] |
6. | Nardone OM, Ponsiglione A, de Sire R, Calabrese G, Liuzzi R, Testa A, Guarino AD, Olmo O, Rispo A, Camera L, Castiglione F. Impact of Sarcopenia on Clinical Outcomes in a Cohort of Caucasian Active Crohn's Disease Patients Undergoing Multidetector CT-Enterography. Nutrients. 2022;14:3460. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 11] [Reference Citation Analysis (0)] |
7. | Ge X, Liu H, Tang S, Wu Y, Pan Y, Liu W, Qi W, Ye L, Cao Q, Zhou W. Preoperative hypoalbuminemia is an independent risk factor for postoperative complications in Crohn's disease patients with normal BMI: A cohort study. Int J Surg. 2020;79:294-299. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 8] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis (0)] |
8. | Subramanian V, Saxena S, Kang JY, Pollok RC. Preoperative steroid use and risk of postoperative complications in patients with inflammatory bowel disease undergoing abdominal surgery. Am J Gastroenterol. 2008;103:2373-2381. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 162] [Cited by in F6Publishing: 156] [Article Influence: 9.8] [Reference Citation Analysis (0)] |
9. | Cohen BL, Fleshner P, Kane SV, Herfarth HH, Palekar N, Farraye FA, Leighton JA, Katz JA, Cohen RD, Gerich ME, Cross RK, Higgins PDR, Tinsley A, Glover S, Siegel CA, Bohl JL, Iskandar H, Ji J, Hu L, Sands BE. Prospective Cohort Study to Investigate the Safety of Preoperative Tumor Necrosis Factor Inhibitor Exposure in Patients With Inflammatory Bowel Disease Undergoing Intra-abdominal Surgery. Gastroenterology. 2022;163:204-221. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 19.0] [Reference Citation Analysis (0)] |
10. | Aberra FN, Lewis JD, Hass D, Rombeau JL, Osborne B, Lichtenstein GR. Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients. Gastroenterology. 2003;125:320-327. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 244] [Cited by in F6Publishing: 226] [Article Influence: 10.8] [Reference Citation Analysis (0)] |
11. | Syed H, Nadeem A, Gardinier D, Weekley K, Ribakow D, Lupe S, Bhat S, Holubar S, Cohen BL. Peri-Operative Optimization of Patients with Crohn's Disease. Curr Gastroenterol Rep. 2024;26:125-136. [PubMed] [DOI] [Cited in This Article: ] [Reference Citation Analysis (0)] |
12. | Iesalnieks I, Hoene M, Bittermann T, Schlitt HJ, Hackl C. Mechanical Bowel Preparation (MBP) Prior to Elective Colorectal Resections in Crohn's Disease Patients. Inflamm Bowel Dis. 2018;24:908-915. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis (0)] |
13. | Hashash JG, Binion DG. Managing Clostridium difficile in inflammatory bowel disease (IBD). Curr Gastroenterol Rep. 2014;16:393. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis (0)] |